Germany

Mon
14
Aug

MedReleaf Reports Q1 Fiscal 2018 Results

MedReleaf Corp. (TSX: LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced financial and operating results for the first quarter fiscal 2018 ending June 30, 2017. All amounts expressed are in Canadian dollars unless otherwise noted.

Wed
09
Aug

The Great Insurance Shuffle: A Schengen Border Dispute Or Something Wider?

It does appear that Europe is actually the place where insurance coverage is going to be defined properly for the first time.

While cannabis reform has certainly arrived, full force, in Europe, it is already a different discussion than anywhere else on the planet.

While the same elements are present in Europe as anywhere else (rec vs. medical, federal vs. regional reform), they are in a different form and focus than is happening in say the U.S. or Canada or Israel.

The most crucial point of this debate, however, right now, is how cannabis is or will be covered by health insurance. Now and into the future. In Europe right now, that has also created a strange standoff across a normally peaceful, open border.

Wed
02
Aug

Why Will Europe Be Slow in Legalising Medical Cannabis

Drug policy usually moves like an iceberg: slowly. And while and it can be hard to turn, sometimes it changes course in an unexpected direction. In the case of cannabis or marijuana, it may be picking up speed, but there are rough waters ahead.

Wed
12
Jul

Aurora Moves One Step Closer To Licensed Production In Germany

From Germany to Canada, Australia to Mexico, the benefits of marijuana are being recognized all over the globe and this trend is just getting started.

One of most significant developments so far this year the legalization of medical marijuana in Germany.

Expect 1+ Million Patients in Germany in the Coming Years

Germany is the largest country (by population) in the European Union and it represents a massive opportunity for marijuana companies. Per the most recent United Nations estimates, the current population of Germany is more than 80.6 million, which is twice the size of California.

Fri
07
Jul

Cannabis Makes Its Way Into the G-20 Summit

The G-20 summit is currently taking place in Hamburg, Germany and marijuana has made its presence known.

Although some of the expected discussion topics include climate change, security and trade, we think medical marijuana will be a topic that takes center stage. 20% of the countries at the G-20 summit have legalized medical marijuana and it will be a topic that is nearly impossible to ignore. Every country is looking for ways to lower its debt level and marijuana is the answer.

Marijuana will not only create a new revenue stream but it will also significantly decrease expenses and allow countries to better allocate its resources.

World Leaders Climb Aboard The Marijuana Train

Wed
31
May

Germany: The Global Cannabis Movement Continues

Germany is becoming a hotbed for Canadian cannabis producers and we think this trend is just getting started. 

Germany, the largest country in the European Union started 2017 by legalizing medical cannabis creating a major opportunity for cannabis businesses across the world. The legislation also will make cannabis available to people suffering from serious illnesses and available through health insurance plans.

These factors have led to a surge in the number of licensed Canadian medical cannabis producers focused on this market and we want to highlight some of the recent deals.

Aurora Makes Major Acquisition

Wed
31
May

OWC Pharmaceutical Research Corp. Enters Into a Strategic Relationship With Germany-Based mediq Innovation Experts

The Initial Objective of the Collaboration is the Introduction of OWC's Active Cannabinoid-Based Topical Psoriasis Cream to the German Market.

OWC Pharmaceutical Research Corp. (OTC: OWCP) and mediq Innovation Partners (mediq) are pleased to announce an agreement for the introduction of OWCP's active cannabinoid-based topical psoriasis cream to the German market.

Frankfurt, Germany-based mediq has extensive experience, knowledge and a successful track record in enabling Israel-based companies to penetrate the European markets. mediq's objectives for OWCP will consist of both scientific collaboration and most importantly the development of a commercial market for OWCP's proprietary, active cannabinoid-based topical psoriasis cream in Germany.

Mon
29
May

Aurora Cannabis acquisition of German marijuana wholesaler could be a game changer

Aurora Cannabis Inc. (TSXV: ACB) announced just before Friday’s closing bell that it plans to acquire Germany’s Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union (EU). Aurora Cannabis’ stock had been halted for more than 24 hours pending this news.

Tue
16
May

Canadian Weed Producers Will Dominate the Global Marijuana Market

“First-mover advantage.” Why Canadian weed producers will dominate the global marijuana market.

In marketing strategy, there’s a term called “first-mover advantage”. It’s when a few key players in a particular industry gain an advantage because they entered into the marketplace first. These companies are able to establish strong brand recognition, shore up the best sources of funding, and build a loyal customer base simply because there aren’t any competitors in the way during their first few years of operation. 

Mon
15
May

How German ethos and humor will shape its cannabis market

There are few places where German culture and cannabis are beginning to interact. Germans are not only accepting about this, but often find it funny. Not to mention the fact that many German firms already in this space, seem to think that all this fuss is downright humorous.

Pages

Subscribe to RSS - Germany